|
|
||||||||
The FASEB Journal, Vol 4, 3319-3328, Copyright © 1990 by The Federation of American Societies for Experimental Biology
REVIEWS |
WA Maltese
Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822.
Isoprenylation is a posttranslational modification that involves the formation of thioether bonds between cysteine and isoprenyl groups derived from pyrophosphate intermediates of the cholesterol biosynthetic pathway. Numerous isoprenylated proteins have been detected in mammalian cells. Those identified include K-, N-, and H- p21ras, ras-related GTP-binding proteins such as G25K (Gp), nuclear lamin B and prelamin A, and the gamma subunits of heterotrimeric G proteins. The modified cysteine is located in the fourth position from the carboxyl terminus in every protein where this has been studied. For p21ras, the last three amino acids are subsequently removed and the exposed cysteine is carboxylmethylated. Similar processing events may occur in lamin B and G protein gamma subunits, but the proteolytic cleavage in prelamin A occurs upstream from the modified cysteine. Lamin B and p21ras are modified by C15 farnesyl groups, whereas other proteins such as the G protein gamma subunits are modified by C20 geranylgeranyl chains. Separate enzymes may catalyze these modifications. The structural features that govern the ability of particular proteins to serve as substrates for isoprenylation by C15 or C20 groups are not completely defined, but studies of the p21ras modification using purified farnesyl:protein transferase suggest that the sequence of the carboxyl-terminal tetrapeptide is important. Isoprenylation plays a critical role in promoting the association of p21ras and the lamins with the cell membrane and nuclear envelope, respectively. Future studies of the role of isoprenylation in the localization and function of ras-related GTP-binding proteins and signal-transducing G proteins should provide valuable new insight into the link between isoprenoid biosynthesis and cell growth.
This article has been cited by other articles:
![]() |
J.-C. Chen, M.-L. Wu, K.-C. Huang, and W.-W. Lin HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression Cardiovasc Res, July 2, 2008; (2008) cvn160v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Carlin, A. J. Peacock, and D. J. Welsh Fluvastatin Inhibits Hypoxic Proliferation and p38 MAPK Activity in Pulmonary Artery Fibroblasts Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 447 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ma, T. Kuno, A. Kita, Y. Asayama, and R. Sugiura Rho2 Is a Target of the Farnesyltransferase Cpp1 and Acts Upstream of Pmk1 Mitogen-activated Protein Kinase Signaling in Fission Yeast Mol. Biol. Cell, December 1, 2006; 17(12): 5028 - 5037. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Efuet and K. Keyomarsi Farnesyl and Geranylgeranyl Transferase Inhibitors Induce G1 Arrest by Targeting the Proteasome Cancer Res., January 15, 2006; 66(2): 1040 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Undas, K. E. Brummel-Ziedins, and K. G. Mann Statins and Blood Coagulation Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Hartman, K. E. Bowers, and C. A. Fierke Lysine {beta}311 of Protein Geranylgeranyltransferase Type I Partially Replaces Magnesium J. Biol. Chem., July 16, 2004; 279(29): 30546 - 30553. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Trovati and F. Cavalot Optimization of Hypolipidemic and Antiplatelet Treatment in the Diabetic Patient with Renal Disease J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S12 - 20. [Abstract] [Full Text] |
||||
![]() |
M.-A. Shibata, C. Kavanaugh, E. Shibata, H. Abe, P. Nguyen, Y. Otsuki, J. B. Trepel, and J. E. Green Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models Carcinogenesis, March 1, 2003; 24(3): 453 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Wheeler, O. M. Smutney, J. F. Check, I. Rusyn, R. Schulte-Hermann, and R. G. Thurman Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G302 - G312. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Carnesecchi, A. Bradaia, B. Fischer, D. Coelho, M. Scholler-Guinard, F. Gosse, and F. Raul Perturbation by Geraniol of Cell Membrane Permeability and Signal Transduction Pathways in Human Colon Cancer Cells J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 711 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Bordier, P. L. Marion, K. Ohashi, M. A. Kay, H. B. Greenberg, J. L. Casey, and J. S. Glenn A Prenylation Inhibitor Prevents Production of Infectious Hepatitis Delta Virus Particles J. Virol., September 11, 2002; 76(20): 10465 - 10472. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, I. Matsuoka, Y. Suzuki, Y. Watanabe, T. Ishibashi, K. Yokoyama, Y. Maruyama, and J. Kimura Inhibitory Effect of Fluvastatin on Lysophosphatidylcholine-Induced Nonselective Cation Current in Guinea Pig Ventricular Myocytes Mol. Pharmacol., September 1, 2002; 62(3): 602 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Crul, G. J. de Klerk, M. Swart, L. J. van't Veer, D. de Jong, L. Boerrigter, P. A. Palmer, C. J. Bol, H. Tan, G. C. de Gast, et al. Phase I Clinical and Pharmacologic Study of Chronic Oral Administration of the Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer J. Clin. Oncol., June 1, 2002; 20(11): 2726 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasunari, K. Maeda, M. Minami, and J. Yoshikawa HMG-CoA Reductase Inhibitors Prevent Migration of Human Coronary Smooth Muscle Cells Through Suppression of Increase in Oxidative Stress Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Satoh, F. Shirota, T. Tsunajima, C. J. Beinlich, H. E. Morgan, and K. Ichihara Limitation of heart growth in neonatal piglets by simvastatin and atorvastatin: comparison with pravastatin Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2746 - H2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ando, T. Takamura, T. Ota, Y. Nagai, and K.-i. Kobayashi Cerivastatin Improves Survival of Mice with Lipopolysaccharide-Induced Sepsis J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1043 - 1046. [Abstract] [Full Text] |
||||
![]() |
J. W. Fenton, G. X. Shen, F. L. Minnear, D. V. Brezniak, J. M. Walenga, J. J. Bognacki, and F. A. Ofosu State-of-the-Art-Review : Statins Induce Hypothrombotic States? Clinical and Applied Thrombosis/Hemostasis, January 1, 2000; 6(1): 18 - 21. [Abstract] [PDF] |
||||
![]() |
C. Indolfi, A. Cioppa, E. Stabile, E. Di Lorenzo, G. Esposito, A. Pisani, A. Leccia, L. Cavuto, A. M. Stingone, A. Chieffo, et al. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury J. Am. Coll. Cardiol., January 1, 2000; 35(1): 214 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Corsini Reviews: Fluvastatin: Effects Beyond Cholesterol Lowering Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(3): 161 - 175. [Abstract] [PDF] |
||||
![]() |
J. A. Urbina, B. Moreno, S. Vierkotter, E. Oldfield, G. Payares, C. Sanoja, B. N. Bailey, W. Yan, D. A. Scott, S. N. J. Moreno, et al. Trypanosoma cruzi Contains Major Pyrophosphate Stores, and Its Growth in Vitro and in Vivo Is Blocked by Pyrophosphate Analogs J. Biol. Chem., November 19, 1999; 274(47): 33609 - 33615. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thai, J. S. Rush, J. E. Maul, T. Devarenne, D. L. Rodgers, J. Chappell, and C. J. Waechter Farnesol is utilized for isoprenoid biosynthesis in plant cells via farnesyl pyrophosphate formed by successive monophosphorylation reactions PNAS, November 9, 1999; 96(23): 13080 - 13085. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rao, D. C. Porter, X. Chen, T. Herliczek, M. Lowe, and K. Keyomarsi Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase PNAS, July 6, 1999; 96(14): 7797 - 7802. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shibata, S. Tanaka, T. Shiraishi, S. Kitano, and M. Mori G-Protein {{gamma}} 7 Is Down-Regulated in Cancers and Associated with P 27kip1-induced Growth Arrest Cancer Res., March 1, 1999; 59(5): 1096 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuzuguchi, Y. Morita, I. Sagami, H. Sagami, and K. Ogura Human Geranylgeranyl Diphosphate Synthase. cDNA CLONING AND EXPRESSION J. Biol. Chem., February 26, 1999; 274(9): 5888 - 5894. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Petras, S. Lindsey, and H. J. Harwood , Jr. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells J. Lipid Res., January 1, 1999; 40(1): 24 - 38. [Abstract] [Full Text] |
||||
![]() |
A. TAN, H. LEVREY, C. DAHM, V. A. POLUNOVSKY, J. RUBINS, and P. B. BITTERMAN Lovastatin Induces Fibroblast Apoptosis In Vitro and In Vivo . A Possible Therapy for Fibroproliferative Disorders Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 220 - 227. [Abstract] [Full Text] |
||||
![]() |
P. Norgaard, B. Law, H. Joseph, D. L. Page, Y. Shyr, D. Mays, J. A. Pietenpol, N. E. Kohl, A. Oliff, R. J. Coffey Jr., et al. Treatment with Farnesyl-Protein Transferase Inhibitor Induces Regression of Mammary Tumors in Transforming Growth Factor (TGF) {{alpha}} and TGF{{alpha}}/neu Transgenic Mice by Inhibition of Mitogenic Activity and Induction of Apoptosis Clin. Cancer Res., January 1, 1999; 5(1): 35 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Engfelt, J. E. Shackelford, N. Aboushadi, N. Jessani, K. Masuda, V. G. Paton, G.-A. Keller, and S. K. Krisans Characterization of UT2 Cells. THE INDUCTION OF PEROXISOMAL 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE J. Biol. Chem., September 26, 1997; 272(39): 24579 - 24587. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raiteri, L. Arnaboldi, P. Mcgeady, M. H. Gelb, D. Verri, C. Tagliabue, P. Quarato, P. Ferraboschi, E. Santaniello, R. Paoletti, et al. J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1144 - 1153. [Abstract] [Full Text] |
||||
![]() |
G. J. Clark, M. S. Kinch, K. Rogers-Graham, S. M. Sebti, A. D. Hamilton, and C. J. Der The Ras-related Protein Rheb Is Farnesylated and Antagonizes Ras Signaling and Transformation J. Biol. Chem., April 18, 1997; 272(16): 10608 - 10615. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yokoyama, K. Zimmerman, J. Scholten, and M. H. Gelb Differential Prenyl Pyrophosphate Binding to Mammalian Protein Geranylgeranyltransferase-I and Protein Farnesyltransferase and Its Consequence on the Specificity of Protein Prenylation J. Biol. Chem., February 14, 1997; 272(7): 3944 - 3952. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ericsson, S. M. Jackson, and P. A. Edwards Synergistic Binding of Sterol Regulatory Element-binding Protein and NF-Y to the Farnesyl Diphosphate Synthase Promoter Is Critical for Sterol-regulated Expression of the Gene J. Biol. Chem., October 4, 1996; 271(40): 24359 - 24364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Frolov, J. K. Woodford, E. J. Murphy, J. T. Billheimer, and F. Schroeder Spontaneous and Protein-mediated Sterol Transfer between Intracellular Membranes J. Biol. Chem., July 5, 1996; 271(27): 16075 - 16083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marom, R. Haklai, G. Ben-Baruch, D. Marciano, Y. Egozi, and Y. Kloog Selective Inhibition of Ras-dependent Cell Growth by Farnesylthiosalisylic Acid J. Biol. Chem., September 22, 1995; 270(38): 22263 - 22270. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Jackson, J. Ericsson, T. F. Osborne, and P. A. Edwards NF-Y Has a Novel Role in Sterol-dependent Transcription of Two Cholesterogenic Genes J. Biol. Chem., September 15, 1995; 270(37): 21445 - 21448. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sagami, A. Kikuchi, and K. Ogura A Novel Type of Protein Modification by Isoprenoid-derived Materials J. Biol. Chem., June 23, 1995; 270(25): 14851 - 14854. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Perillo, I. Tedesco, C. Laezza, M. Santillo, A. Romano, S. M. Aloj, and M. Bifulco Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Gene Expression in FRTL-5 Cells J. Biol. Chem., June 23, 1995; 270(25): 15237 - 15241. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Kalman, R. A. Erdman, W. A. Maltese, and J. D. Robishaw Regions Outside of the CAAX Motif Influence the Specificity of Prenylation of G Protein [IMAGE] Subunits J. Biol. Chem., June 16, 1995; 270(24): 14835 - 14841. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Corsini, D. Verri, M. Raiteri, P. Quarato, R. Paoletti, and R. Fumagalli Effects of 26-Aminocholesterol, 27-Hydroxycholesterol, and 25-Hydroxycholesterol on Proliferation and Cholesterol Homeostasis in Arterial Myocytes Arterioscler. Thromb. Vasc. Biol., March 1, 1995; 15(3): 420 - 428. [Abstract] [Full Text] |
||||
![]() |
H Hennekes and E. Nigg The role of isoprenylation in membrane attachment of nuclear lamins. A single point mutation prevents proteolytic cleavage of the lamin A precursor and confers membrane binding properties J. Cell Sci., January 4, 1994; 107(4): 1019 - 1029. [Abstract] [PDF] |
||||
![]() |
G. James, J. Goldstein, M. Brown, T. Rawson, T. Somers, R. McDowell, C. Crowley, B. Lucas, A. Levinson, and J. Marsters Jr Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells Science, June 25, 1993; 260(5116): 1937 - 1942. [Abstract] [PDF] |
||||
![]() |
J. Glenn, J. Watson, C. Havel, and J. White Identification of a prenylation site in delta virus large antigen Science, May 29, 1992; 256(5061): 1331 - 1333. [Abstract] [PDF] |
||||
![]() |
B H Morimoto, C C Chuang, and D E Koshland Molecular cloning of a member of a new class of low-molecular-weight GTP-binding proteins. Genes & Dev., December 1, 1991; 5(12b): 2386 - 2391. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |